FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.
Al-Tamari HM, Dabral S, Schmall A, Sarvari P, Ruppert C, Paik J, DePinho RA, Grimminger F, Eickelberg O, Guenther A, Seeger W, Savai R, Pullamsetti SS.
Al-Tamari HM, et al. Among authors: ruppert c.
EMBO Mol Med. 2018 Feb;10(2):276-293. doi: 10.15252/emmm.201606261.
EMBO Mol Med. 2018.
PMID: 29217661
Free PMC article.